TGFB1 and renal cell carcinoma: Considering that targeted drugs are commonly used in the treatment of metastatic RCC, we evaluated the efficacy of different targeted drugs on the TGF-β signaling pathway in the KEGG-TGF-β high-score and low-score groups.